NovoCure Ltd
Ticker: 1645113
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 183.58+5.5% | 174.06+4.1% | 167.20+5.3% | 158.81+2.5% | 154.99-0.1% | 155.10+3.2% | 150.36+8.6% | 138.50 |
| Total Income | 183.58+5.5% | 174.06+4.1% | 167.20+5.3% | 158.81+2.5% | 154.99-0.1% | 155.10+3.2% | 150.36+8.6% | 138.50 |
| EXPENSES | ||||||||
| Expenditure | 194.15-19.6% | 241.48+18.8% | 203.23+2.5% | 198.33+2.8% | 192.86+3.0% | 187.19+1.8% | 183.94+2.2% | 180.02 |
| Tax | 3.21+70.7% | 1.88-74.1% | 7.25+40.5% | 5.16+28.4% | 4.02-55.3% | 8.99-15.6% | 10.65+49.6% | 7.12 |
| PROFIT | ||||||||
| PBT | -12.45+82.0% | -69.26-130.7% | -30.02+14.2% | -34.98-15.4% | -30.30-40.3% | -21.59+5.0% | -22.73+28.2% | -31.64 |
| Net Profit | -15.66+78.0% | -71.14-90.9% | -37.27+7.1% | -40.14-17.0% | -34.32-12.3% | -30.57+8.4% | -33.38+13.9% | -38.76 |
| KEY METRICS | ||||||||
| OPM % | -5.75%+32.98pp | -38.73%-17.19pp | -21.54%+3.34pp | -24.89%-0.46pp | -24.43%-3.74pp | -20.69%+1.64pp | -22.33%+7.64pp | -29.98% |
| NPM % | -8.53%+32.34pp | -40.87%-18.58pp | -22.29%+2.99pp | -25.28%-3.13pp | -22.14%-2.43pp | -19.71%+2.49pp | -22.20%+5.79pp | -27.98% |
| EPS | -0.13+79.0% | -0.62-87.9% | -0.33+8.3% | -0.36-16.1% | -0.31-10.7% | -0.28+9.7% | -0.31+13.9% | -0.36 |
Corporate Events
Board MeetingNVCR
20262Sep
Board Meeting
Director Retirement - Timothy Scannell retired from the Boar…
SEC Filing ↗ Board MeetingNVCR
20263Jun
Board Meeting
Annual General Meeting — Election of directors and approval …
SEC Filing ↗ Board MeetingNVCR
20268Apr
Board Meeting
Uri Weinberg appointed as Chief Medical Officer, effective A…
SEC Filing ↗